KR20020037241A - Synthesis and characterization of new chitosan derivatives by use of amino acid - Google Patents
Synthesis and characterization of new chitosan derivatives by use of amino acid Download PDFInfo
- Publication number
- KR20020037241A KR20020037241A KR1020000068252A KR20000068252A KR20020037241A KR 20020037241 A KR20020037241 A KR 20020037241A KR 1020000068252 A KR1020000068252 A KR 1020000068252A KR 20000068252 A KR20000068252 A KR 20000068252A KR 20020037241 A KR20020037241 A KR 20020037241A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- chitosan
- amino
- compound
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 43
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 15
- 230000015572 biosynthetic process Effects 0.000 title description 11
- 238000003786 synthesis reaction Methods 0.000 title description 11
- 238000012512 characterization method Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 239000000575 pesticide Substances 0.000 claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- -1 N-formyl amino Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000021736 acetylation Effects 0.000 claims description 2
- 238000006640 acetylation reaction Methods 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000001014 amino acid Nutrition 0.000 claims 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 239000011248 coating agent Substances 0.000 claims 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 150000008064 anhydrides Chemical class 0.000 claims 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 2
- 235000019253 formic acid Nutrition 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 239000003674 animal food additive Substances 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 229960002449 glycine Drugs 0.000 claims 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims 1
- 238000005984 hydrogenation reaction Methods 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 238000003976 plant breeding Methods 0.000 claims 1
- 238000006116 polymerization reaction Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 239000004753 textile Substances 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 229920005615 natural polymer Polymers 0.000 abstract 1
- 229920002101 Chitin Polymers 0.000 description 12
- 239000000126 substance Substances 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 150000001556 benzimidazoles Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 241000235646 Cyberlindnera jadinii Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012449 sabouraud dextrose agar Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000131500 Chionoecetes opilio Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 108010089807 chitosanase Proteins 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 키토산 유도체로서 식용으로 유용한 하기 화학식 (I)로 표시되는 키토산을 이용한 천연 고분자 항균아미노산 그의 제조 방법 및 이들의 응용방법 등으로서의 효능 및 용도에 관한 것이다.The present invention relates to a method for producing a natural polymer antimicrobial amino acid using chitosan represented by the following general formula (I), which is useful for food, as a chitosan derivative, and to its efficacy and use as an application method thereof.
Description
본 발명은 현재 쓰이고 있는 천연 항균제인 키토산 유도체로서 하기 구조식[Ⅰ]의 신규한 키토산 유도체 및 그의 제조방법에관한 것이다.The present invention relates to a novel chitosan derivative of the following structural formula [I] as a chitosan derivative which is a natural antimicrobial agent currently used, and a method for producing the same.
상기식에서 구조식[I], [II]의 화합물은 키토산에 아미노산 및 유기산이 결합된 구조를 갖는다. 최근 의약 및 식품분야에서 신물질 창출은 우리나라가 당면하고 있는 과학기술 분야의 문제중에서 가장 시급하게 해결해야할 과제중의 하나라고 할 수 있다. 한편 최근 식품등에 과다한 농약 첨가로 인한 잔류농약 문제가 인체에 미치는 영향은 날로 심각한 상태이며, 최근 메스컴 보도에서도 심각성을 보도한 바와 같이 농약 사용이 사용 기준치의 한계를 크게 웃도는등 이로인한 식품 섭취에 따를 건강 피해는 성인은 물론 2차 감염등으로 신생아에서 부터 태아에 이르기 까지 건강에 큰 위협이되고 있다. 그러나 아직까지도 항산화제제들과 과다한 농약이 사용되고 있으며 또한 포르말린 살포등으로 여러가지 잔류농약제가 건강에 큰 위협이되고 있다. 그러한 가운데 최근 천연물 소제인 키틴 키토산의 항균 및 항진균 효능을 이용하는 다각적인 연구가 활발히 이루어지고 있다 할 수 있다.In the above formula, the compounds of structural formulas [I] and [II] have a structure in which amino acids and organic acids are bonded to chitosan. In recent years, the creation of new materials in medicine and food is one of the most urgent tasks to be solved among the problems of science and technology. Meanwhile, the effects of pesticide residue on the human body due to excessive addition of pesticides to foods are serious, and as reported recently in the media, the use of pesticides greatly exceeds the limit of the standard of use. Health damage is a serious threat to health from newborns to fetuses as well as secondary infections as well as adults. However, antioxidants and excessive pesticides are still used, and various residual pesticides are a major threat to health due to formalin spraying. In the meantime, various studies using the antibacterial and antifungal efficacy of chitin chitosan, a natural product, have been actively conducted.
특히 키토산은 새우, 게 등의 갑각류와 곤충, 버섯, 세균의 세포벽 등에 광범위하게 존재하고 있는 물질로 지구상에 셀루로스 다음으로 많은 양이 생성되고 있는 바이오 메스물질이다. 이 키토산은 식물계의 셀루로스와 같이 생물체의 외골격을 형성하여 지지나 방호 역할을 담당하는 물질이 키틴질을 가수분해하여 얻어지며 키틴질은 아미노기가 아세틸化된 N-아세틸-D-그루코사민이β-1, 4 결합된 고분자 다당체로서 존재한다. 먼저, NaOH나 KOH를 이용 탈단백질을 한후 5%의 HCl용액에서 칼슘을 포함한 무기물질을 제거하면 불용성 물질이 남게 되는데 이것이 키틴이다. 이 키틴을 진한 알카리 수용액에서 열을 가하면서 가수분해 시킨 물질이 키토산이다. 이렇게 가수분해 시킬 때 탈아세틸化 시키는 정도에 따라 본 연구팀이 개발 하고자 하는 chitosan 유도체는 또 생리활성 증대물질로서 유사한 약제들은 유일하게 chitosan 자체가 갖는 아미노기 양전하의 특성 효과로 항균력이 천연물 자체로서도 우수하다. 그래서 이를 응용하여 특이한 화학구조를 이루고 있으나 항균성에 탁월한 활성 효염이 있는 NH2-Chitosan 유도체를 합성하기 위하여 일부 보고된 일반적인 키토산 항균제 유도체인 연구 학술적 자료 보고에 국한된 틀을 벗어나 실용화될수 있는 순수 천연물질 소재로 합성을 시도하고 또한 천연 아미노산을 이용하여 이를 화학적인 방법으로 커풀링을 시도하려고 한다. 그래서 이지역 특산물로 대량 활용 가능한 천연물질인 천연소재 또는 아미노산류 및 생리 활성물질을 이용하여 키토산과 새로운 화합물을 합성하여 보다 항균활성이 증가된 새로운 리드 화합물로의 식품첨가제인 항균제를 개발하고자 하였다. 그래서 과일로부터 화학결합적 가교 가능성 있는 항균성 항균활성 물질 분리 와 천연 생고분자인 키토산 및 키틴을 이용한 활성물질과의 합성 그리고 Amino acid 와 키토산 및 키틴과의 유도체 합성하여 이에대한 전 임상실험을 통하여 최종 후보물질을 확정 하고 신규성으로 키토산이 물에 안녹는것에 비해서 물에 잘 녹는특이성이 발견되어 출원하고자 합니다.In particular, chitosan is a substance that is present in a wide range of shells such as shrimp and crabs, and the cell walls of insects, mushrooms, and bacteria. This chitosan is obtained by hydrolyzing chitin by a substance that forms an exoskeleton of an organism like cellulose of a plant, and supports or protects the chitin, and β- 1 by N-acetyl-D-glucosamine where the amino group is acetylated. , 4-linked polymer polysaccharides. First, demineralization using NaOH or KOH and then removing calcium-containing inorganic substances from 5% HCl solution leaves insoluble substances. This is chitin. Chitosan is a substance that hydrolyzes chitin in concentrated alkaline aqueous solution. According to the degree of deacetylation during hydrolysis, the chitosan derivatives that the team intends to develop are also biologically active substances, and similar drugs are the only ones that have superior antimicrobial activity as natural products due to the characteristic effect of the positive charge of amino groups in chitosan itself. Therefore, it is a pure natural material that can be put to practical use beyond the scope of the research academic data, which is a common chitosan antimicrobial derivative reported in order to synthesize NH 2 -Chitosan derivative which has a specific chemical structure but has an active effect excellent in antimicrobial activity. In addition, it attempts to synthesize by using a natural amino acid and to try to couple it by chemical method. Therefore, by using chitosan and new compounds by using natural materials or amino acids and physiologically active substances, which are mass materials that can be used as a special product of this region, we tried to develop an antimicrobial agent as a food additive as a new lead compound with increased antibacterial activity. Therefore, the final candidates were obtained through the preclinical experiments on the separation of antimicrobial antimicrobial active substance with chemically crosslinking potential from fruit, the synthesis of active substance using natural chitosan and chitin, and the synthesis of Amino acid and chitosan and chitin. We have decided to apply for the discovery of a substance and the uniqueness of water dissolving in chitosan.
..
제 1도는 아미노산을 이용한 키토산과의 결합방법을 나타냄1 shows a method of binding to chitosan using amino acids
제 2도는 아세틸기 함유에 따른 유기산을 이용한 키토산과의 결합방법을 나타냄2 shows a method of binding to chitosan using an organic acid containing acetyl group.
제 3도는 유기산을 이용한 키토산과의 결합방법을 나타냄3 shows a method of binding to chitosan using an organic acid.
실시예 1Example 1
2. 재료 및 방법(연구방법)2. Materials and Methods (Research Methods)
2-1. 재료2-1. material
2-1-1. 본 실험에 사용한 키틴은 전남 목포시 소재 바이오테크(사)에서 붉은 대게(Chinoecetes japonicus) 각질로 부터 추출한 것으로 일정한 크기로 마쇄(50mesh)하여 0-5℃의 냉장고에 보관하여 두고 실험에 사용하였다.2-1-1. The chitin used in this experiment was extracted from keratin (Chinoecetes japonicus) keratin from Biotech Co., Ltd., Mokpo-si, Jeonnam, and ground to a constant size (50mesh) and stored in a refrigerator at 0-5 ℃ for use in the experiment.
2-1-2. 합성한 Benzimidazole치환 키토산 유도체 화합물에 대한 Minimum Inhibitory Concentration(MICin vitro)의 측정2-1-2. Measurement of Minimum Inhibitory Concentration (MIC in vitro ) on Synthesized Benzimidazole-Substituted Chitosan Derivatives
2-1-2-1.사용균주2-1-2-1.Use strain
본 실험에 사용한 미생물은Escherichia coli0157:H7 균과 진균으로Candida utilis,Candida albicansATCC 10231,Saccharomyces cerevisiaeATCC9763 ,Aspergillus niger9029 을 사용하였다.The microorganisms used in this experiment were Escherichia coli 0157: H7 and fungi Candida utilis , Candida albicans ATCC 10231, Saccharomyces cerevisiae ATCC9763 and Aspergillus niger 9029.
2-1-2-2. 사용배지2-1-2-2. Used badge
본 실험에 사용한 세균용 배지: Mueller Hinton broth, Mueller Hinton ager이며 진균용 배지: Sabouraud Dextrose Broth, Sabouraud Dextrose agar로 조정하여 사용하였다.Bacterial media used in this experiment: Mueller Hinton broth, Mueller Hinton ager and fungal media: Sabouraud Dextrose Broth, Sabouraud Dextrose agar.
2-1-2-3. 시약 및 사용기기2-1-2-3. Reagents and Equipment
시약 및 용매는 Aldrich사 제품을 그대로 사용하였고, 분리한 화합물을 확인하는데 사용한 기기중 융점 측정은 Thomas Hoover melting point Apparatus를 사용하였으며 보정은 하지 않았다. 핵자기공명 분광기는 Varain T60과 HA-100을 사용하였다. 적외선 분광기는 Bio-Red FTS-45A Spectrophotometer를 사용하여 얻었다. T.L.C plate는 Merck DC-plastik follen Kieselgsl 60F 254를 사용하고, 키토산은 탈아세틸화도가 89%, 점도 20cps이며, Bacillus pumilus BM- 유래 chitosanase (분자량: 약 30,000 Da, 최저 pH: 5.5∼605, 최적온도: 30∼50℃, 등전점: 약 93)은 Wakopure Chemical사 (대, 日本)에서 구입하였으며, D-글루코사민은 Sigma Chemical사 (St. Louis, USA)에서 구입하였다. 키토산 유도체 합성을 위한 아미노산인 Gly, Ala, Asp Asn, Boc-S-(p-methoxybenzyl)-L-Cys 및 Boc-L-Met와 합성 촉매제인 DCC (N,N'-dicyclohexyl-carbodiimide)는 Sigma Chemical사로부터 구입하여 사용하였다.Reagents and solvents were used as Aldrich Co., Ltd. The melting point of the instrument used to identify the separated compound was measured by Thomas Hoover melting point Apparatus was not calibrated. The nuclear magnetic resonance spectrometer used Varain T60 and HA-100. Infrared spectroscopy was obtained using a Bio-Red FTS-45A Spectrophotometer. TLC plate uses Merck DC-plastik follen Kieselgsl 60F 254, chitosan has 89% deacetylation, viscosity 20cps, chitosanase derived from Bacillus pumilus BM- (molecular weight: about 30,000 Da, minimum pH: 5.5 ~ 605, optimum temperature) : 30 to 50 ° C., isoelectric point: about 93) was purchased from Wakopure Chemical Co., Ltd., Japan, and D-glucosamine was purchased from Sigma Chemical Co., Ltd. (St. Louis, USA). The amino acids Gly, Ala, Asp Asn, Boc-S- (p-methoxybenzyl) -L-Cys and Boc-L-Met for synthesis of chitosan derivatives and DCC (N, N'-dicyclohexyl-carbodiimide) as a synthesis catalyst are Sigma It was purchased from Chemical Company.
2-2. 방법2-2. Way
2-2-1. 메탄올 추출물 조제와 검정 배지 제조 및 항미생물 활성 측정:2-2-1. Preparation of methanol extract and assay medium and determination of antimicrobial activity:
1). 균희석액을 만들기 위해 전배양은 균의 농도가 104-106CFU/ml가 되게 희섞한다.One). To make the fungal diluent, preculture is mixed with a concentration of 10 4 -10 6 CFU / ml.
2). 각 검체를 알맞은 용매로 녹인 후 배지로 2배 희석법으로 희석한다.2). Each sample is dissolved in a suitable solvent and then diluted in 2-fold dilution with medium.
3). 각각의 시험관에 균액을 접종한다.3). Inoculate each test tube with bacterial solution.
4). 세균은 37도 24시간 배양하며 진균은 36-48 시간 배양한다.4). Bacteria are incubated at 37 degrees for 24 hours and fungi are incubated for 36-48 hours.
5). 각 배양이 끝난 후 시험관을 흔들어 균의 탁도를 확인한다.탁도 여부를 확인한 후 각각을 Mueller Hinton ager, Sabouraud Dextrose agar배지에 제 접종하여 확인한다.5). After each incubation, shake the test tube to check the turbidity of the bacteria. After checking the turbidity, check each of them by re-inoculating each of Mueller Hinton ager and Sabouraud Dextrose agar.
6). 균의 성장여부를 확인한 후 성장이 인정되지 않는 가장 낮은 농도의 시험관 농도를 정하여 상기와 같은 액체배지 희석법(Broth Serial Dilution Method)으로 MIC를 정한다.6). After confirming the growth of the bacteria, determine the lowest test tube concentration at which growth is not recognized and determine the MIC by the broth serial dilution method as described above.
2-2-2. 각 화합물에 대한 항균 활성효과:2-2-2. Antimicrobial activity against each compound:
합성 화합물과 대조 화합물로 chitosan에 대한 in vitro에서 최소발육 저지농도(MIC, (㎍/ml))에 대한 측정결과는 Table 1에 수록 하였다.Measurement results for the synthetic compound and control compound minimum inhibitory concentration in the i n vitro for the chitosan in (MIC, (㎍ / ml) ) was given in Table 1.
2-2-3. Chitosan의 제조2-2-3. Manufacture of Chitosan
붉은 대게 껍질로부터 키틴의 추출은 갑각류 껍질 중량에 대하여 35배의 4N HCl를 가하여 탈회분화 시킨 다음 1N NaOH 용액을 사용하여 1시간 반응시켜 탈 단백질화 하였다. 이후 0.5%의 과망간산 칼륨으로 탈색시킨 후 여과 및 수세공정을 거쳐 열풍건조기로 60℃에서 건조하여 키틴을 제조하였다Chitin was extracted from the red snow crab shells and demineralized by adding 35 times of 4N HCl to the crustacean shell weight, followed by 1 hour reaction with 1N NaOH solution for deproteinization. Then, decolorized with 0.5% potassium permanganate, filtered, washed with water, and dried at 60 ° C. using a hot air dryer to prepare chitin.
2-4. Acetyl화 측정2-4. Acetylation Measurement
본 연구에서 분리한 키틴, 키토산의 원소분석 결과와 완전한 키틴 키토산 원소분석 결과와의 질량% 결과로부터 N/C에 따른 계산값으로 환산하여 비교하였다.In this study, the mass% results of the chitin and chitosan elemental analysis and the chitin chitosan elemental analysis were compared and calculated in terms of N / C.
실시예 2Example 2
2-5-1. Benzimidazole을 이용한 Benzimidazole유도체 합성2-5-1. Benzimidazole Derivative Synthesis Using Benzimidazole
1. 중간 유도체 화합물(3b) 합성1. Synthesis of Intermediate Derivative Compound (3b)
삼구 둥근 플라스크 50 ml에 화합물(2) 1.5 g을 녹이고 여기에 황산 13 ml와 질산 10 ml를 5℃이하에서 10분간 넣고 20분간 반응 시켰다. 그리고 혼합용액을 얼음물30 ml에 분산 시키고 방치한 다음 생성된 결정화합물1.8 g을 얻었다. 다시 이혼합물을 건조시킨 다음 칼럼 크로마토그래피를 이용하여 분리해서 2 위치에 치환된 노란색 결정화합물 0.7 g을 얻었다.1.5 g of Compound (2) was dissolved in 50 ml of a three-necked round flask, and 13 ml of sulfuric acid and 10 ml of nitric acid were added thereto for 10 minutes at 5 ° C. or lower and allowed to react for 20 minutes. The mixed solution was dispersed in 30 ml of iced water and left to obtain 1.8 g of the resulting crystal compound. The mixture was dried again and separated by column chromatography to obtain 0.7 g of a yellow crystalline compound substituted at the 2nd position.
실시예 3Example 3
2. 중간 유도체 화합물(4) 합성2. Synthesis of Intermediate Derivative Compound (4)
재 증류한 EtOH 30 ml에 화합물(3b) 10.5 g (0.06 mole)을 녹이고 Pd-C를 가하여 교반한 다음 수소가스를 통과시키면서 반응이 완료될때까지 환원반응을 진행하였다. 반응이 완료되면 혼합물을 걸르고 에탄올 10 ml로 다시 세척한 다음 여액을 모아 감압농축한 다음 생성된 결정화합물을 건조하여 7.72 g을 얻었다.10.5 g (0.06 mole) of Compound (3b) was dissolved in 30 ml of re-distilled EtOH, and stirred with Pd-C, followed by a reduction reaction until the reaction was completed while passing hydrogen gas. After the reaction was completed, the mixture was filtered, washed with 10 ml of ethanol again, and the filtrate was concentrated under reduced pressure, and the resulting crystal compound was dried to yield 7.72 g.
수율: 88.2%Yield: 88.2%
실시예 4Example 4
3. Benzimidazole유도체 합성3. Synthesis of Benzimidazole Derivative
100 ml 삼구풀라스크에 PPA 27 ml에 화합물(5) 1.5g (0.014 mole)을 녹이고이어서β-PA를 0.014 mole을 가하면서 90℃ 이상에서 6시간동안 반응시킨 다음 생성된 결정화합물을 모으고 이를 건조시킨 다음 에탄올 60 ml 로 재 결정하여 화합물(6)을 1.32 g을 얻었다.Dissolve 1.5 g (0.014 mole) of compound (5) in 27 ml of PPA in 100 ml three-necked pusque, then react β- PA with 0.014 mole for 6 hours at 90 ° C or more, collect the resulting crystals and dry it. After recrystallization with 60 ml of ethanol to give 1.32 g of compound (6).
실시예 5Example 5
4. Benzimidazole유도체를 이용한 키토산 유도체 합성(A)4.Synthesis of Chitosan Derivatives Using Benzimidazole Derivatives (A)
재 증류한 DMF 80 ml에 화합물 chitosan 5.5 g을 넣고 이어서 화합물(6)을 키토산기준 1/2 mole 넣은 다음 80℃ 이상에서 6시간동안 반응시킨 다음 생성된 결정화합물을 모으고 이를 증류수 50 ml, 에탄올 60 ml, ether 60 ml 순으로 씻어준 다음 키토산 유도체화합물(7)을 6.13 g 얻었다.5.5 g of the compound chitosan was added to 80 ml of re-distilled DMF, followed by adding 1/2 mole of the compound (6) to the chitosan standard and reacting at 80 ° C. or higher for 6 hours. The resultant crystals were collected and 50 ml of distilled water and 60 ethanol were added. After washing with 60 ml of ether and 6.13 g of chitosan derivatives (7) were obtained.
실시예 6Example 6
5. Benzimidazole유도체를 이용한 키토산 유도체 합성(B)5.Synthesis of Chitosan Derivatives Using Benzimidazole Derivatives (B)
빙초산 3%-EtOH 혼합용액 30 ml에 화합물 chitosan 1.5 g을 넣고 이어서 화합물(8)을 키토산기준 1/3 mole 넣은 후 10시간동안 교반한 다음 pH처리후 생성된 결정화합물을 모으고 이를 증류수 50 ml, 에탄올 60 ml, ether 60 ml 순으로 씻어준 다음 키토산 유도체화합물(7)을 1.2 g 얻었다.1.5 g of the compound chitosan was added to 30 ml of a mixture of glacial acetic acid 3% -EtOH, and then compound (8) was added to 1/3 mole of chitosan standard, stirred for 10 hours, and then the resulting crystal compound was collected and 50 ml of distilled water was collected. After washing with 60 ml of ethanol and 60 ml of ether, 1.2 g of chitosan derivative compound (7) was obtained.
실시예 7Example 7
6-2). 화합물에 대한 항균 활성효과:6-2). Antimicrobial Activity on Compounds:
합성 화합물과 대조 화합물로 chitosan에 대한 in vitro에서 최소발육 저지농도(MIC, (㎍/ml))에 대한 측정결과는 Table 1에 수록 하였다.Measurement results for the synthetic compound and control compound minimum inhibitory concentration in the i n vitro for the chitosan in (MIC, (㎍ / ml) ) was given in Table 1.
각 화합물에 대한 항 미생물의 활성관계:Activity of antimicrobial activity for each compound:
키토산 유도체을 pH 4.9-5.0 로 조절한 묽은 초산용액을 액체배지에서 배양하면서 최소저해농도를 측정한 결과는 표 1.과 같다.The results of measuring the minimum inhibitory concentrations while culturing the diluted acetic acid solution in which the chitosan derivative was adjusted to pH 4.9-5.0 in a liquid medium are shown in Table 1.
합성한 화합물(A)의 최소저해농도는Candida albicansATCC 10231,Candida utilis, Saccharomyces cerevisiaeATCC 9763,Aspergillus niger9029등 에서는 모두 300 ㎍/ ㎖,250㎍/ ㎖,600㎍/ ㎖,400㎍/ ㎖로 키토산에 비하여 비교적 낮은 농도에서 생육이 억제되었으나, 세균에서는 E.coli균주가 800㎍/ ㎖로 가장 높게 나타났다. 한편 화합물(B)는Candida albicansATCC 10231이 300 ㎍/ ㎖로 화합물(A)와 같게 나타났으나Candida utilis, Saccharomyces cerevisiaeATCC 9763,Aspergillus niger9029인 균류에는 화합물(A)에 비교했을 때 비교적 활성 이 낮았다. 그러나 이들 키토산 -벤지미다졸성 화합물들은 전반적으로 키토산 보다항진규 활성도가 7-10배정도 항균활성을 나타냈다.The minimum inhibitory concentration of the synthesized compound (A) was 300 ㎍ / ㎖, 250 ㎍ / ㎖, 600 ㎍ / ㎖, 400 ㎍ / ㎖ with Candida albicans ATCC 10231, Candida utilis, Saccharomyces cerevisiae ATCC 9763, Aspergillus niger 9029, etc. Growth was inhibited at a relatively low concentration compared to chitosan, but E. coli strain was the highest in bacteria at 800 µg / ml. Meanwhile, the compound (B) is relatively free of activity when it is compared with the compound (A) Candida albicans ATCC 10231 is shown the same as compound (A) to 300 ㎍ / ㎖ nateu or Candida utilis, Saccharomyces cerevisiae ATCC 9763, Aspergillus niger 9029 of the fungus Low. However, these chitosan-benzimidazole compounds showed antibacterial activity about 7-10 times higher than chitosan.
..
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000068252A KR20020037241A (en) | 2000-11-12 | 2000-11-12 | Synthesis and characterization of new chitosan derivatives by use of amino acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000068252A KR20020037241A (en) | 2000-11-12 | 2000-11-12 | Synthesis and characterization of new chitosan derivatives by use of amino acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20020037241A true KR20020037241A (en) | 2002-05-18 |
Family
ID=19699536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020000068252A Ceased KR20020037241A (en) | 2000-11-12 | 2000-11-12 | Synthesis and characterization of new chitosan derivatives by use of amino acid |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20020037241A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010106359A (en) * | 2001-10-30 | 2001-11-29 | 조석형 | Chelate compound for animals feed |
| US8119780B2 (en) | 2006-06-02 | 2012-02-21 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
| CN105113053A (en) * | 2015-08-27 | 2015-12-02 | 常州大学 | Preparation method of hyaluronic acid derivative /chitosan derivative compound polyelectrolyte bi-crosslinking fiber |
-
2000
- 2000-11-12 KR KR1020000068252A patent/KR20020037241A/en not_active Ceased
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010106359A (en) * | 2001-10-30 | 2001-11-29 | 조석형 | Chelate compound for animals feed |
| US8119780B2 (en) | 2006-06-02 | 2012-02-21 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
| US8658775B2 (en) | 2006-06-02 | 2014-02-25 | Shenda Baker | Chitosan-derivative compounds and methods of controlling microbial populations |
| US9029351B2 (en) | 2006-06-02 | 2015-05-12 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
| US9732164B2 (en) | 2006-06-02 | 2017-08-15 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
| CN105113053A (en) * | 2015-08-27 | 2015-12-02 | 常州大学 | Preparation method of hyaluronic acid derivative /chitosan derivative compound polyelectrolyte bi-crosslinking fiber |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Savin et al. | Antioxidant, cytotoxic and antimicrobial activity of chitosan preparations extracted from Ganoderma lucidum mushroom | |
| Gomaa | Microbial chitinases: properties, enhancement and potential applications | |
| Tajdini et al. | Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus | |
| US7556946B2 (en) | Cell wall derivatives from biomass and preparation thereof | |
| Hu et al. | Synthesis, characterization and antibacterial activity of guanidinylated chitosan | |
| Feng et al. | Preparation, characterization and antibacterial activity of water-soluble O-fumaryl-chitosan | |
| EP2451845B1 (en) | Preservatives from chitin derivatives | |
| Affes et al. | Preparation of a crude chitosanase from blue crab viscera as well as its application in the production of biologically active chito-oligosaccharides from shrimp shells chitosan | |
| CN105237655B (en) | Marine organism polysaccharide Schiff base derivative, preparation method thereof, and application thereof as agricultural bactericide | |
| WO2022165940A1 (en) | Chitosan derivative, preparation method therefor and application thereof | |
| Sharma et al. | A review on valorization of chitinous waste | |
| JP2615444B2 (en) | Partially N-acylated chitooligosaccharide or salt thereof | |
| Chen et al. | Preparation of wood ear medicinal mushroom, Auricularia auricula-judae (Agaricomycetes), melanin and its antioxidant properties: evaluation in vitro and in vivo | |
| KR20020037241A (en) | Synthesis and characterization of new chitosan derivatives by use of amino acid | |
| CN105566510B (en) | A kind of Portugal's oligosaccharides and its preparation method and application | |
| KR20050025395A (en) | Synthesis and characterization of new chitosan derivatives | |
| KR100441270B1 (en) | The Method for Preparation of Water Soluble Free Amine Chitosan | |
| KR101113729B1 (en) | Process for Preparation of Middle Molecular Chitosan Having Antibacterial Activity against Antibiotic Resistance Bacteria and Uses thereof | |
| KR19990064910A (en) | Anti-microbial activity of chitin/chitosan oligomers and surfactants derived from chitin/chitosan | |
| E Dawwam et al. | A prospective chitosan produced from a biological source: Extraction, Characterization, and Assessment of biological performance | |
| CN107880153A (en) | 6 Carboxy Chitosan aromatic series quaternary ammonium salt derivatives and its preparation and application | |
| Moorthy et al. | Synthesis of N alkyl chitosan and their impact on biology and physiology of fall armyworm, Spodoptera frugiperda | |
| JPH08333213A (en) | Antivirus / bacterial agent | |
| RU2269542C1 (en) | Modified chitosan | |
| Bharathi et al. | Characterization and applications of pullulan and chitosan produced by fermentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20001112 |
|
| PG1501 | Laying open of application | ||
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
Patent event date: 20050129 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20051108 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20001112 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20061019 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20070427 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20061019 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |